Inotuzumab Ozogamicin 1 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 1 mg

Reference Brands: Besponsa (USA/LATAM)

Category: Oncology Cancer Care

Inotuzumab Ozogamicin is a Oncology Cancer Care product available as Injection in strengths 1 mg. It corresponds to the reference brand Besponsa (USA/LATAM). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Inotuzumab ozogamicin is a targeted anticancer therapy classified as a monoclonal antibody–drug conjugate (ADC) used primarily for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The medicine combines a humanized monoclonal antibody that specifically targets the CD22 antigen found on malignant B cells with a potent cytotoxic agent called calicheamicin. Once the drug binds to CD22-positive leukemia cells, it is internalized into the cell, where the cytotoxic component is released to damage DNA and trigger cell death. This targeted approach helps deliver the chemotherapy directly to cancer cells while limiting exposure to normal tissues.

Inotuzumab ozogamicin has shown significant effectiveness in patients who have not responded well to previous treatments or whose disease has returned after therapy. It can help achieve remission and may serve as a bridge to stem cell transplantation in eligible patients. However, treatment requires careful monitoring because the drug can cause side effects, including low blood cell counts, infections, and liver-related complications. One of the most important risks associated with this therapy is sinusoidal obstruction syndrome, a serious liver condition that can occur during or after treatment. Due to these potential risks, therapy is typically managed by oncology specialists with regular clinical and laboratory monitoring to ensure patient safety and treatment effectiveness.